Clustered Regularly Interspaced Short Palindromic Repeat
- All
- News
-
Profluent Announces AI Gene Editor Generator OpenCRISPR to Enable Creating Bespoke Cures for Diseases
- Wednesday April 24, 2024
- Written by Akash Dutta, Edited by Siddharth Suvarna
Profluent, a California-based artificial intelligence (AI)-first protein design company, announced its AI model that can generate CRISPR-like proteins that do not occur in nature on Tuesday. CRISPR or Clustered Regularly Interspaced Short Palindromic Repeats is a complex containing important proteins that scientists can use for precise gene editing...
- www.gadgets360.com
-
Drug Controller Approves Commercial Launch Of Low Cost Covid Test "Feluda"
- Sunday September 20, 2020
- India News | Press Trust of India
The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday.
- www.ndtv.com
-
New Gene Editing Technique May Treat Inherited Blindness
- Monday January 11, 2016
- Health | Press Trust of India
A new technique that has the potential to treat inherited diseases has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, scientists say.
- www.ndtv.com
-
Profluent Announces AI Gene Editor Generator OpenCRISPR to Enable Creating Bespoke Cures for Diseases
- Wednesday April 24, 2024
- Written by Akash Dutta, Edited by Siddharth Suvarna
Profluent, a California-based artificial intelligence (AI)-first protein design company, announced its AI model that can generate CRISPR-like proteins that do not occur in nature on Tuesday. CRISPR or Clustered Regularly Interspaced Short Palindromic Repeats is a complex containing important proteins that scientists can use for precise gene editing...
- www.gadgets360.com
-
Drug Controller Approves Commercial Launch Of Low Cost Covid Test "Feluda"
- Sunday September 20, 2020
- India News | Press Trust of India
The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday.
- www.ndtv.com
-
New Gene Editing Technique May Treat Inherited Blindness
- Monday January 11, 2016
- Health | Press Trust of India
A new technique that has the potential to treat inherited diseases has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, scientists say.
- www.ndtv.com